HIV Rapid Test | SINGAPORE SEXUALHEALTH™
HIV Rapid Test | SINGAPORE SEXUALHEALTH™ @singaporesexualhealth_com: HIV (human immunodeficiency virus) rapid test, Singapore. Private & confidential service.
Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
| SHIM CLINIC|
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: HIV Rapid Test | SINGAPORE SEXUALHEALTH™
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
Table of Contents HIV rapid test (20 minutes to results) Two types are available:
Note: If the clinic attendance is only for the HIV rapid test, then consultation fees are not added.
References HIV is the abbreviation for the human immunodeficiency virus, which causes the acquired immunodeficiency syndrome
HIV symptoms which may present in acute HIV infection: These are nonspecific symptoms and can present with other infections; consequently, they are unreliable indicators of HIV infection.
Remember, there is no HIV cure.
HIV window period is the time from HIV infection until a HIV Test can detect any change. Within the HIV window period, the HIV Test would be negative. During this period, the HIV viral load is extremely high, thus making the person highly infectious.
References HIV Test
- 4 weeks after exposure, a negative 4th generation HIV ELISA Test "is very reassuring / highly likely to exclude HIV infection."
- 12 weeks after exposure, a negative 3rd generation HIV ELISA Test "would definitively exclude HIV infection."
HIV ELISA (Enzyme-linked immunosorbent assay) test generations:
References HIV PCR (polymerase chain reaction) NAT (nucleic acid test) HIV Risk (2009 figures)
- 1st generation: HIV-1 IgG antibody
- 2nd generation: HIV-1 & HIV-2 IgG antibodies
- 3rd generation: HIV-1 & HIV-2 IgG & IgM antibodies
- 4th generation: HIV-1 & HIV-2 IgG & IgM antibodies and HIV p24 antigen
Estimated HIV transmission risk per exposure for specific activities and events
|Activity ||Risk-per-exposure |
|Vaginal sex, female-to-male, studies in high-income countries ||0.04% (1:2380) |
|Vaginal sex, male-to-female, studies in high-income countries ||0.08% (1:1234) |
|Vaginal sex, female-to-male, studies in low-income countries ||0.38% (1:263) |
|Vaginal sex, male-to-female, studies in low-income countries ||0.30% (1:333) |
|Vaginal sex, source partner is asymptomatic ||0.07% (1:1428) |
|Vaginal sex, source partner has late-stage disease ||0.55% (1:180) |
|Receptive anal sex amongst gay men, partner unknown status ||0.27% (1:370) |
|Receptive anal sex amongst gay men, partner HIV positive ||0.82% (1:123) |
|Receptive anal sex with condom, gay men, partner unknown status ||0.18% (1:555) |
|Insertive anal sex, gay men, partner unknown status ||0.06% (1:1666) |
|Insertive anal sex with condom, gay men, partner unknown status ||0.04% (1:2500) |
|Receptive fellatio ||Estimates range from 0.00% to 0.04% (1:2500) |
|Mother-to-child, mother takes at least two weeks antiretroviral therapy ||0.8% (1:125) |
|Mother-to-child, mother takes combination therapy, viral load below 50 ||0.1% (1:1000) |
|Injecting drug use ||Estimates range from 0.63% (1:158) to 2.4% (1:41) |
|Needlestick injury, no other risk factors ||0.13% (1:769) |
|Blood transfusion with contaminated blood ||92.5% (9:10) |
Sources: vaginal sex;1 anal sex;2 fellatio;3 2 mother-to-child;4 other activities.5
- Boily MC et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9(2): 118-129, 2009
- Vittinghoff E et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. American Journal of Epidemiology 150: 306-311, 1999
- Del Romero J et al. Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS 16(9): 1296-1297, 2002
- Townsend C et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 22: 973-981, 2008
- Baggaley RF et al. Risk of HIV-1 transmission for parenteral exposure and blood transfusion. AIDS 20: 805-812, 2006
- HIV & AIDS Information :: How transmission occurs - Estimated risk per exposure
HIV Risk (2005 figures)
Estimated per-act risk for acquisition of HIV, by exposure route*
*Estimates of risk for transmission from sexual exposures assume no condom use.
|Exposure route||Risk per 10,000|
to an infected source
|Needle-sharing injection-drug use||67||0.67|
|Receptive anal intercourse||50||0.5|
|Percutaneous needle stick||30||0.3|
|Receptive penile-vaginal intercourse||10||0.1|
|Insertive anal intercourse||6.5||0.065|
|Insertive penile-vaginal intercourse||5||0.05|
|Receptive oral intercourse†||1||0.01|
|Insertive oral intercourse†||0.5||0.005|
†Source refers to oral intercourse performed on a man.
HIV risk (2002 figures)
HIV Risk Statistics (chances of getting HIV)
|HIV Risk Factors ||HIV Transmission Probability |
|Needle stick injury3 ||1/300 |
|Receptive anal intercourse4 ||1/100 |
|Receptive vaginal intercourse5 ||1/1000 |
|Insertive vaginal intercourse4 ||1/2000 |
|Insertive anal intercourse4 ||1/2500 |
|Receptive fellatio with ejaculation4 ||1/2500 |
|Sharing needles6 ||1/150 |
HIV prevention / HIV PEP (post-exposure prophylaxis) treatment can prevent you from getting an HIV infection, and turning HIV positive.
- Cardo DM, Culver DH, Ciesielski CA, et al. A Case-Control Study of HIV Seroconversion in Health Care Workers after Percutaneous Exposure. N Engl J Med. 1997;337:1485-1490.
- Katz MH, Gerberding JL. Management of occupational and nonoccupational postexposure HIV prophylaxis. Current Inf Dis Reports. 2002;4:543-549.
- Gerberding JL. Prophylaxis for Occupational Exposure to HIV. Ann Intern Med. 1996;6:497-501
- Vitinghoff E, Douglas J, Judon F, et al. Per-Contact Risk of Human Immunodificiency Virus Transmision between Male Sexual Partners. Am J Epidemiol. 1999;150:306-311.
- Peterman TA, Stoneburner RL, Allen JR, et al. Risk of Human Immunodeficiency Virus Transmission From Heterosexual Adults With Transfusion-Associated Infections. JAMA. 1988;259:55-58. [Erratum. JAMA. 1989;262:502]
- Kaplan EH, Heimer R. A Model-Based Estimate of HIV Infectivity via Needle Sharing. J Acquir Immune Defic Syndr. 1992;5:1116-1118.
Individuals are eligible for HIV PEP Treatment if all the following criteria are met:
Prompt antiviral therapy may reduce the risk of HIV transmission by as much as 80%.
- less than 72 hours has elapsed since exposure;
- the exposed individual is not known to be HIV infected;
- the person who is the source of exposure is HIV infected or has unknown HIV status;
- mucous membrane or non-intact skin was exposed to a potentially infectious body fluid;
For optimal efficacy, antiretroviral therapy should be started as soon as possible, ideally within 1 hour of exposure. So that you can remain HIV negative.
The medications and dosages are the same as those used for lifelong treatment of HIV patients. However, for HIV PEP treatment, it is taken for only a month.
References Drugs commonly used in HIV PEP: References TORCH
(of HIV/STD/pregnancy), and what you can do before and after exposure.
Cytochrome P450 2B6 genetic variants are associated with plasma nevirapine levels and clinical response in HIV-1 infected Kenyan women: a prospective cohort study.
Fri, 17 Apr 2015 16:22:02 +0100 | AIDS Research and Therapy
CONCLUSIONS: CYP2B6 516G>T and CYP2B6 983T>C genotypes were strongly associated with plasma nevirapine concentration, which predicted immunologic response in women on nevirapine-based antiretroviral therapy. These data support continued work on the potential utility of human genetic testing to inform nevirapine dosage optimization for individual patients.
[Correspondence] HIV incidence and mortality in China
Fri, 17 Apr 2015 10:15:42 +0100 | LANCET
We read with interest, the Global Burden of Disease Study (GBD) by Christopher Murray and colleagues1 reporting global, regional, and national estimates of HIV/AIDS incidence and mortality for 1990–2013, which included an estimate of 35 665 new HIV cases and 12 145 deaths in China in 2013. This number of deaths is almost a third lower than the 19 716 deaths reported for the same year by the National Center for AIDS/STD Control and Prevention (NCAIDS) within the Chinese Center For Disease Control and Prevention (CDC). (Source: LANCET)
Alcohol Use and Associated Sexual and Substance Use Behaviors Among Men Who Have Sex with Men in Moscow, Russia
Fri, 17 Apr 2015 09:52:37 +0100 | AIDS and Behavior
This study explored relationships between alcohol use and behavioral risks for HIV transmission among men who have sex with men (MSM) in Moscow, Russia. Alcohol use disorder identification test (AUDIT) scores for 1367 MSM participating in a cross-sectional survey and HIV testing were categorized to: “abstinence/low use”, “hazardous use”, “harmful use/dependency”. Multiple logistic regression models compared dependent variables for sexual and drug use behaviors across alcohol use strata. Hazardous and harmful/dependent alcohol use were significantly associated with high-risk sexual behaviors and drug use. Harmful use/dependency was associated with an increased odds of having more than five male sex partners (last 12 months; adjusted odds ratios—AOR 1.69; 95 % CI 1.25–2.27)...
Rwanda: Gasabo District Gets New HIV Clinic, Laboratory
Fri, 17 Apr 2015 09:17:33 +0100 | AllAfrica News: HIV-Aids and STDs
[New Times] The AIDS Healthcare Foundation (AHF) - Rwanda yesterday inaugurated a new HIV clinic and laboratory at Kabuye Health Centre in Gasabo District. (Source: AllAfrica News: HIV-Aids and STDs)
Africa: The Case for Keeping Viral Hepatitis in the SDGs
Fri, 17 Apr 2015 08:10:11 +0100 | AllAfrica News: Health and Medicine
[SciDev.Net] Globally, viral hepatitis kills an estimated 1.5 million people each year - a death toll comparable to HIV/AIDS. The chronic disease caused by hepatitis B and C viruses accounts for 78 per cent of all cases of liver cancer, which is the second most common cause of cancer deaths after lung cancer. (Source: AllAfrica News: Health and Medicine)
Botswana: ACHAP Track Record Speaks Volumes
Fri, 17 Apr 2015 07:26:19 +0100 | AllAfrica News: HIV-Aids and STDs
[Botswana Daily News] Gaborone -The African Comprehensive HIV/AIDS Partnerships (ACHAP) prides itself on various achievements and looks forward to continuous partnerships with the government and other stakeholders in the fight against HIIV/AIDS and Tuberculosis. (Source: AllAfrica News: HIV-Aids and STDs)
Epidemiology and management of antiretroviral-associated cardiovascular disease.
Fri, 17 Apr 2015 06:48:02 +0100 | Open AIDS Journal
Authors: Chastain DB, Henderson H, Stover KR
Kenya: 17 Per Cent Youth Have HIV, Says NACC
Fri, 17 Apr 2015 06:45:26 +0100 | AllAfrica News: HIV-Aids and STDs
[The Star] Seventeen per cent of AIDs related deaths every year occur among adolescents and youth, the National Aids Control Council has said. (Source: AllAfrica News: HIV-Aids and STDs)
Kenya: Wanted - Anti-HIV Messaging for the Age of Social Media
Fri, 17 Apr 2015 06:10:09 +0100 | AllAfrica News: HIV-Aids and STDs
[The Star] THE National Aids Control Council says 17 per cent of Aids-related deaths occur among adolescents and youth. This is a distressing statistic and strikes right at the heart of the nation's future. (Source: AllAfrica News: HIV-Aids and STDs)
Number of Drinks to “Feel a Buzz” by HIV Status and Viral Load in Men
Fri, 17 Apr 2015 00:00:00 +0100 | AIDS and Behavior